Navigation Links
New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
Date:9/30/2013

New York, NY (PRWEB) September 30, 2013

China’s newly diagnosed female breast cancer patients are expected to outnumber those in the United States for the first time in 2015, according to new data from Kantar Health’s CancerMPact® Patient Metrics – Expanded Markets. The number of newly diagnosed women in China is expected to continue to increase to more than 300,000 per year by 2040.

The number of breast cancer patients diagnosed annually has increased by over 50 percent since 2004. In 2012 China had 225,000 new cases of breast cancer, compared with 149,000 in 2004. In the U.S., the number of patients newly diagnosed with breast cancer increased by only 17 percent over this same period. Incidence of breast cancer is still much higher in China’s urban population than in rural areas, but the rural incidence rate has been growing faster in recent years, narrowing the gap between urban and rural areas. In addition, the mean age of diagnosis of breast cancer is approximately nine years younger in China than it is in the U.S. or Europe.

These data were drawn from CancerMPact® Patient Metrics – Expanded Markets, which builds upon Kantar Health's gold-standard epidemiology for the G7 markets by combining epidemiologic data and analysis to estimate incidence by stage, five-year prevalence and treatable patients in 10 tumor types in Argentina, Brazil, Canada, China, India, Mexico, Russia, South Korea, Taiwan and Turkey:

  •     Breast
  •     Colorectal
  •     Gastric
  •     Hepatocellular carcinoma
  •     Multiple myeloma
  •     Non-Hodgkin’s lymphoma
  •     Non-small cell lung
  •     Ovarian
  •     Pancreatic
  •     Prostate

“Historically, China has had one of the lowest incidence rates of breast cancer, especially when compared with Western countries,” said David Robinson, Vice President, Kantar Health. “However, incidence has risen much more quickly over the past two decades than it has in other countries, mainly due to the general aging of the population and increased adoption of Westernized diets. Our data suggest that these factors will likely lead to continued increases in incidence.”

About CancerMPact®
CancerMPact® is an invaluable oncology decision support resource for market analysis, strategic planning and identification of commercial opportunities in the U.S., Western Europe, Japan and China. This resource is composed of web-based integrated modules: Treatment Practices and Evolution (Treatment Architecture and Future Trends and Insights) and Patient Metrics (Patient Metrics – G7, Patient Metrics – Expanded Markets and Biomarker Analysis).

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11169194.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
2. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
3. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
4. Kantar Health Launches CancerMPact Biomarker Analysis
5. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
6. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
7. Kantar Health to Present at PBIRG Annual General Meeting
8. AACR honors Hagop Kantarjian for outstanding clinical research
9. Kantar Health to Participate in CIO Summit of America Conference
10. Kantar Health Further Strengthens Its Advanced Methods and Client Consulting Capabilities in the UK
11. In-Depth Health Claim Review Saves Client Up to $15,000 on Surgery that Fails to Meet Standards for Medical Necessity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Tampa, FL (PRWEB) , ... February 17, 2017 ... ... a premier sponsor and exhibitor at Molecular Medicine Tri-Conference February 20 – 22 ... through Wednesday, Inspirata will showcase its anatomic and molecular pathology workflow solution, as ...
(Date:2/17/2017)... ... February 17, 2017 , ... Top neuroendocrine cancer doctors, nurses and specialists ... from February 21 - 23 in Beaver Creek, CO. It was announced today by ... second year in Beaver Creek, hosting over 60 faculty members and addressing unmet needs ...
(Date:2/17/2017)... FL (PRWEB) , ... February 17, 2017 , ... ... services and financial planning assistance to families and business owners in the greater ... LifeNet 4 Families organization. , For more than 30 years, LifeNet 4 ...
(Date:2/16/2017)... ... 17, 2017 , ... For some cancer survivors, the memories ... Physician researchers at The Marcus Institute of Integrative Health at Thomas Jefferson ... reducing symptoms of traumatic stress in cancer patients and published their results ...
(Date:2/16/2017)... ... 2017 , ... The Price Agency, a Jefferson County-based firm ... the Birmingham area, is announcing an ongoing charity event to help raise support ... son, Anius. , Anius is medically complex with diagnoses consisting and not limited ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... , Feb. 17, 2017   Parker ... protecting the rights of victims injured by medical ... regulators to call for better reporting. Congress required ... Safety concerns involving power morcellators and duodenoscopes ... to investigate how hospitals report injuries and deaths ...
(Date:2/17/2017)... February 17, 2017 Cryoablation, Electrical, Endometrial Hydrothermal, ... The global ablation technologies market is expected to grow at a ... The market is expected to grow at a CAGR of 9.5% ... 2016, and $9.05bn in 2026. ... How this report will benefit you Read on ...
(Date:2/17/2017)... 2017 Arvinas LLC, a private biotechnology company ... degradation, today announced the presentation of new preclinical data ... poster session at the American Society of Clinical Oncology ... Orlando, FL. "The new ... the potential of PROTACs to drive durable and robust ...
Breaking Medicine Technology: